Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13818194 | 1.00 | KDM4E (0.31) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL15813209 | 0.94 | TFPI2 (0.33) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL13784893 | 0.94 | TFPI2 (0.33) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL658709 | 0.94 | TFPI2 (0.33) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL14510049 | 0.94 | TFPI2 (0.33) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL15980921 | 0.94 | TFPI2 (0.33) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL9924687 | 0.91 | TFPI2 (0.32) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL13398885 | 0.91 | KDM4E (0.35) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL19477981 | 0.87 | — | — | |
| SCHEMBL14560663 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212133-A1 | Safe, Environmentally Friendly and Controllable Method for Preparing Cycloaliphatic Diepoxides | JIANGSU TETRA NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212133-A1 | Safe, Environmentally Friendly and Controllable Method for Preparing Cycloaliphatic Diepoxides | DDT, EPHX2, HSD11B2 | KDM4E 2774/4885GMNN 4863/4885LMNA 3361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.